Table 1.
Demographics of patients treated at Stanford Cancer Institute and TCGA
| Characteristic | Stanford patients (n = 152) | TCGA (n = 206) |
|---|---|---|
| Age at diagnosis | 54.5 (15–90) | 60 (20–90) |
| Sex | ||
| Male | 74 (48.7%) | 94 (46%) |
| Female | 78 (51.3%) | 112 (54%) |
| Race or ethnic group | ||
| Caucasian | 104 (68%) | N/A |
| Hispanic | 22 (14%) | |
| Asian | 22 (14%) | |
| Other | 4 (3%) | |
| Tumor histology | ||
| Leiomyosarcoma | 25 | 80 |
| Undifferentiated pleomorphic sarcoma | 23 | 44 |
| Sarcoma (NOS) | 14 | |
| Myxofibrosarcoma | 13 | 17 |
| Liposarcoma | 13 | 50 |
| Malignant peripheral nerve sheath tumor | 9 | 5 |
| Synovial sarcoma | 7 | 10 |
| Osteosarcoma | 5 | |
| Angiosarcoma | 5 | |
| Rhabdomyosarcoma | 3 | |
| Ewing’s sarcoma | 3 | |
| Chondrosarcoma | 3 | |
| Malignant phyllodes tumor | 3 | |
| Local or metastatic | ||
| Local | 106 (70%) | 89 (43%) |
| Locally advanced | 8 (5%) | |
| Metastatic | 38 (25%) | 46 (22%) |
| Unknown | 71 (34%) | |
| Site | ||
| Extremity | 46 (30%) | 62 (30%) |
| Pelvic | 31 (20%) | 33 (16%) |
| Trunk | 15 (10%) | 9 (4%) |
| Retroperitoneum | 21 (14%) | 87 (42%) |
| Spine | 9 (6%) | 0 |
| Breast | 6 (4%) | 0 |
| Lungs | 4 (3%) | 2 (1%) |
| Other | 10 (7%) | 13 (6%) |
| Size (cm) | 11.4 (2–42) | 12.7 (1.2–39.5) |
| FNCLCC grade | ||
| I | 7 (5%) | 14 (7%) |
| II | 23 (15%) | 112 (54%) |
| III | 37 (24%) | 80 (39%) |
| N/A | 85 (56%) | |
| Adjuvant chemotherapy | ||
| Yes | 48 (41%) | 47 (23%) |
| No | 70 (59%) | 150 (73%) |
| N/A | 9 (4%) | |
| Adjuvant radiotherapy | ||
| Yes | 78 (66%) | 58 (28%) |
| No | 37 (31%) | 139 (67%) |
| N/A | 9 (4%) | |